Label: INGROWN NAIL TREATMENT- jalawef ingrown nail treatment liquid

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated June 13, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Active Ingredient

    Clove oil 6%

    Cnidium Monnieri Extract 5%

  • Purpose

    Ingrown Toenail Treatment

  • Use

    (Usage)
    1.Cleanse and dry affected nails.

    2.Directly apply the product to the affected area (you can use a cotton swab for application).

    3.Place the nail patch over the affected area and allow it to soften.

    4. After softening the nail, use the file to shape the nail.

  • Warnings

    For external use only

    Keep out of the reach of children.

  • Do not use

    Avoidcontact with eyes and mouth. Donot use it on the irritated skin. Notsuitable for pregnant andbreastfeeding.

  • When Using

    Apply the product directly to the affected area (can be used with a cotton swab).

  • Stop Use

    lf swallowed, get medicalassistance or contact the poison control center.

  • Ask Doctor

    lf swallowed, get medicalassistance or contact the poison control center.

  • Keep Oot Of Reach Of Children

    Keep out of the reach of children.

  • Directions

    DIRECTION:
    Wash and dry affected nails
    Apply the product directly to the affected area (can be used with a cotton swab).
    Place the nail patch over the affected area and wait for it to soften.
    After softening the nail, use the file to shape the nail.

  • Other information

    store at room temperature

    avoid excessive heat 37°C (99°F)

  • Inactive ingredients

    Aloe vera 5%
    Salicylic acid 5%
    Ethanol 30%
    Purified water 22%
    Eugenol 10%
    Shea butter 12%
    Lactic Acid 5%

  • Questions

    1-9146081258

  • PRINCIPAL DISPLAY PANEL

    1

  • INGREDIENTS AND APPEARANCE
    INGROWN NAIL TREATMENT 
    jalawef ingrown nail treatment liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:83299-029
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    CNIDIUM MONNIERI FRUIT (UNII: V1IA3S3CUS) (CNIDIUM MONNIERI FRUIT - UNII:V1IA3S3CUS) CNIDIUM MONNIERI FRUIT5 g  in 100 mL
    CLOVE OIL (UNII: 578389D6D0) (CLOVE OIL - UNII:578389D6D0) CLOVE OIL6 g  in 100 mL
    Inactive Ingredients
    Ingredient NameStrength
    ALOE VERA LEAF (UNII: ZY81Z83H0X)  
    SALICYLIC ACID (UNII: O414PZ4LPZ)  
    WATER (UNII: 059QF0KO0R)  
    SHEA BUTTER (UNII: K49155WL9Y)  
    ALCOHOL (UNII: 3K9958V90M)  
    EUGENOL (UNII: 3T8H1794QW)  
    LACTIC ACID (UNII: 33X04XA5AT)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:83299-029-0120 mL in 1 BOTTLE; Type 0: Not a Combination Product06/13/2024
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00506/13/2024
    Labeler - Consilii LLC (118891890)
    Establishment
    NameAddressID/FEIBusiness Operations
    Consilii LLC118891890label(83299-029) , manufacture(83299-029)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!